Cargando…
Lack of durable natriuresis and objective decongestion following SGLT2 inhibition in randomized controlled trials of patients with heart failure
Patients with heart failure have increased cardiac filling pressures, circulating natriuretic peptides, and physical signs of fluid retention, which are related to sodium retention by the kidneys and are alleviated by conventional diuretics. Sodium-glucose cotransporter 2 (SGLT2) inhibitors interfer...
Autor principal: | Packer, Milton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399057/ https://www.ncbi.nlm.nih.gov/pubmed/37533009 http://dx.doi.org/10.1186/s12933-023-01946-w |
Ejemplares similares
-
Fasting-Induced Natriuresis and SGLT: A New Hypothesis for an Old Enigma
por: Heyman, Samuel N., et al.
Publicado: (2020) -
Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial
por: ter Maaten, Jozine M., et al.
Publicado: (2023) -
Decongestion: Diuretics and other therapies for hospitalized heart failure
por: Vazir, Ali, et al.
Publicado: (2016) -
Empagliflozin and Protecting Microvascular Support of Heart Mechanics: SGLT2 Inhibition or More?
por: Mantsounga, Chris Sorel, et al.
Publicado: (2019) -
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
por: Biegus, Jan, et al.
Publicado: (2022)